eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference May 8, 2023 08:00AM
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference Jun 7, 2022 08:00AM
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference Jun 7, 2022 08:00AM
eFFECTOR Therapeutics to Participate in The JMP Securities Hematology and Oncology Summit Nov 22, 2021 08:00AM
eFFECTOR Therapeutics to Participate in The JMP Securities Hematology and Oncology Summit Nov 22, 2021 08:00AM


Sep 21, 2021 05:13AM UPDATE: JMP Securities Starts eFFECTOR Therapeutics, Inc. (EFTR) at Market Outperform
Aug 25, 2021 07:18PM eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer Therapies
May 27, 2021 08:02AM eFFECTOR Therapeutics and Locust Walk Acquisition (LWAC) Announce Merger Agreement
May 27, 2021 08:00AM eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies